Please wait while the formulary information is being retrieved.
Drug overview for MUCINEX D (guaifenesin/pseudoephedrine hcl):
Generic name: GUAIFENESIN/PSEUDOEPHEDRINE HCL (gweye-FEN-eh-sin/sue-doh-eff-ED-rin)
Drug class: Amphetamines/Anorexiants/Stimulants
Therapeutic class:
Guaifenesin is an expectorant. Pseudoephedrine is a sympathomimetic agent that occurs naturally in plants of the genus Ephedra; the drug acts directly on both alpha- and, to a lesser degree, beta-adrenergic receptors.
Pseudoephedrine is used as a nasal decongestant for self-medication for the temporary relief of nasal congestion associated with upper respiratory allergy and to provide temporary relief of sinus congestion and pressure. The drug also has been used for self-medication in the symptomatic prevention of otitic barotrauma+ (aerotitis ( barotitis) media). Pseudoephedrine also has been misused for clandestine synthesis of methamphetamine and methcathinone for illicit use.
Generic name: GUAIFENESIN/PSEUDOEPHEDRINE HCL (gweye-FEN-eh-sin/sue-doh-eff-ED-rin)
Drug class: Amphetamines/Anorexiants/Stimulants
Therapeutic class:
Guaifenesin is an expectorant. Pseudoephedrine is a sympathomimetic agent that occurs naturally in plants of the genus Ephedra; the drug acts directly on both alpha- and, to a lesser degree, beta-adrenergic receptors.
Pseudoephedrine is used as a nasal decongestant for self-medication for the temporary relief of nasal congestion associated with upper respiratory allergy and to provide temporary relief of sinus congestion and pressure. The drug also has been used for self-medication in the symptomatic prevention of otitic barotrauma+ (aerotitis ( barotitis) media). Pseudoephedrine also has been misused for clandestine synthesis of methamphetamine and methcathinone for illicit use.
DRUG IMAGES
- MUCINEX D ER 600-60 MG TABLET
The following indications for MUCINEX D (guaifenesin/pseudoephedrine hcl) have been approved by the FDA:
Indications:
None.
Professional Synonyms:
None.
Indications:
None.
Professional Synonyms:
None.